-
1
-
-
0025933431
-
Antiestrogen resistance: Mechanisms by which cancer cells undermine the effectiveness of endocrine therapy
-
Katzenellenbogen BS. Antiestrogen resistance: mechanisms by which cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst (Bethesda) 1991;83:1433-5.
-
(1991)
J Natl Cancer Inst (Bethesda)
, vol.83
, pp. 1433-1435
-
-
Katzenellenbogen, B.S.1
-
2
-
-
0032569831
-
Tamoxifen in the treatment of breast cancer
-
Osborne C. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998;339:1609-18.
-
(1998)
N Engl J Med
, vol.339
, pp. 1609-1618
-
-
Osborne, C.1
-
3
-
-
0036488531
-
Endocrine-responsive breast cancer and strategies for combatting resistance
-
Ali S, Coombs CR. Endocrine-responsive breast cancer and strategies for combatting resistance. Nat Rev Cancer 2002;2:101-12.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 101-112
-
-
Ali, S.1
Coombs, C.R.2
-
4
-
-
0021133540
-
Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines
-
Westley B, May FEB, Brown AMC, et al. Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines. J Biol Chem 1984;259:10030-5.
-
(1984)
J Biol Chem
, vol.259
, pp. 10030-10035
-
-
Westley, B.1
May, F.E.B.2
Brown, A.M.C.3
-
5
-
-
0019797751
-
Isolation and characterization of tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells
-
Nawata H, Bronzert D, Lippman ME. Isolation and characterization of tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J Biol Chem 1981;256:5016-21.
-
(1981)
J Biol Chem
, vol.256
, pp. 5016-5021
-
-
Nawata, H.1
Bronzert, D.2
Lippman, M.E.3
-
6
-
-
0030016280
-
Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-estrogen ICI 182780 in women with advanced breast cancer
-
Howell A, DeFriend DJ, Robertson JF, et al. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-estrogen ICI 182780 in women with advanced breast cancer. Br J Cancer 1996;74:300-8.
-
(1996)
Br J Cancer
, vol.74
, pp. 300-308
-
-
Howell, A.1
DeFriend, D.J.2
Robertson, J.F.3
-
7
-
-
0020003085
-
Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth
-
Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982;42:317-23.
-
(1982)
Cancer Res
, vol.42
, pp. 317-323
-
-
Coezy, E.1
Borgna, J.L.2
Rochefort, H.3
-
8
-
-
0021235629
-
The antiproliferative effect of tamoxifen in breast cancer cells: Mediation by the estrogen receptor
-
Bardon S, Vignon F, Derocq D, Rochefort H. The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Mol Cell Endocrinol 1984;35:89-96.
-
(1984)
Mol Cell Endocrinol
, vol.35
, pp. 89-96
-
-
Bardon, S.1
Vignon, F.2
Derocq, D.3
Rochefort, H.4
-
9
-
-
0026557343
-
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 Randomised trials involving 31,000 recurrences and 24,000 deaths among 75000 women
-
Early Breast Cancer Trialists' Collaborative Group
-
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet 1992;339:1-15, 71-85.
-
(1992)
Lancet
, vol.339
, pp. 1-15
-
-
-
10
-
-
0016755280
-
Current status of estrogen receptors in human breast cancer
-
Mc Guire WL. Current status of estrogen receptors in human breast cancer. Cancer (Phila) 1975;36:638-44.
-
(1975)
Cancer (Phila)
, vol.36
, pp. 638-644
-
-
Mc Guire, W.L.1
-
11
-
-
0033386954
-
Estrogen receptor β - A new dimension in estrogen mechanism of action
-
Gustafsson JA. Estrogen receptor β-a new dimension in estrogen mechanism of action. J Endocrinol 1999;163:379-83.
-
(1999)
J Endocrinol
, vol.163
, pp. 379-383
-
-
Gustafsson, J.A.1
-
12
-
-
0019411776
-
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues
-
Borgna JL, Rochefort H. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J Biol Chem 1981;256:859-68.
-
(1981)
J Biol Chem
, vol.256
, pp. 859-868
-
-
Borgna, J.L.1
Rochefort, H.2
-
13
-
-
0031039888
-
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β
-
Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinology 1997;138:863-70.
-
(1997)
Endocrinology
, vol.138
, pp. 863-870
-
-
Kuiper, G.G.J.M.1
Carlsson, B.2
Grandien, K.3
-
14
-
-
0037148424
-
Expression of oestrogen receptor beta (ERβ1) protein in human breast cancer biopsies
-
Saunders PTK, Millar MR, Williams K, Macpherson S, Bayne C, O'Sullivan C, Anderson TJ, Groome NP, Miller WR. Expression of oestrogen receptor beta (ERβ1) protein in human breast cancer biopsies. Br J Cancer 2002;86:250-256.
-
(2002)
Br J Cancer
, vol.86
, pp. 250-256
-
-
Saunders, P.T.K.1
Millar, M.R.2
Williams, K.3
Macpherson, S.4
Bayne, C.5
O'Sullivan, C.6
Anderson, T.J.7
Groome, N.P.8
Miller, W.R.9
-
16
-
-
0034641862
-
Estrogen receptor β acts as a dominant regulator of estrogen signaling
-
Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 2000;19: 4970-8.
-
(2000)
Oncogene
, vol.19
, pp. 4970-4978
-
-
Pettersson, K.1
Delaunay, F.2
Gustafsson, J.A.3
-
17
-
-
0030801841
-
Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites
-
Paech K, Webb P, Kuiper GGJM, et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science (Wash DC) 1997;277:1508-10.
-
(1997)
Science (Wash DC)
, vol.277
, pp. 1508-1510
-
-
Paech, K.1
Webb, P.2
Kuiper, G.G.J.M.3
-
18
-
-
0025062215
-
Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context-dependent agonistic activity of the antiestrogen 4-hydroxytamoxifen
-
Berry M, Metzger D, Chambon P. Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context-dependent agonistic activity of the antiestrogen 4-hydroxytamoxifen. EMBO. J 1990;9:2811-8.
-
(1990)
EMBO J
, vol.9
, pp. 2811-2818
-
-
Berry, M.1
Metzger, D.2
Chambon, P.3
-
19
-
-
0033856986
-
Functional differences between the amino-terminal domains of estrogen receptors α and β
-
Delaunay F, Pettersson K, Tujague M, Gustafsson JA. Functional differences between the amino-terminal domains of estrogen receptors α and β. Mol Pharmacol 2000;58:584-90.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 584-590
-
-
Delaunay, F.1
Pettersson, K.2
Tujague, M.3
Gustafsson, J.A.4
-
20
-
-
0036533986
-
Breast cancer consensus meetings: Vive la difference
-
Davidson NE, Levine M. Breast cancer consensus meetings: vive la difference. J Clin Oncol 2002;20:1719-20.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1719-1720
-
-
Davidson, N.E.1
Levine, M.2
-
21
-
-
70449185514
-
Histological grading and prognosis in breast cancer
-
Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-77.
-
(1957)
Br J Cancer
, vol.11
, pp. 359-377
-
-
Bloom, H.J.G.1
Richardson, W.W.2
-
22
-
-
0001271962
-
Grading of invasive carcinoma of the breast
-
Page D, Andreson T, editors. Edinburgh: Churchill Livingstone
-
Elston, C. Grading of invasive carcinoma of the breast. In: Page D, Andreson T, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone; 1987. p. 300-11.
-
(1987)
Diagnostic Histopathology of the Breast
, pp. 300-311
-
-
Elston, C.1
-
23
-
-
0035866760
-
Decreased expression of estrogen receptor β protein in prolliferative preinvasive mammary tumors
-
Roger P, Esslimani Sahla M, Makela S, Gustafsson JA, Baldet P, Rochefort H. Decreased expression of estrogen receptor β protein in prolliferative preinvasive mammary tumors. Cancer Res 2001;61:2537-41.
-
(2001)
Cancer Res
, vol.61
, pp. 2537-2541
-
-
Roger, P.1
Esslimani Sahla, M.2
Makela, S.3
Gustafsson, J.A.4
Baldet, P.5
Rochefort, H.6
-
24
-
-
0034602787
-
Estrogen receptors α et β in the rodent mammary gland
-
Saji S, Jensen EV, Nilsson S, Rylander T, Warner M, Gustafsson JA. Estrogen receptors α et β in the rodent mammary gland. Proc Natl Acad Sci USA 2000;97:337-42.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 337-342
-
-
Saji, S.1
Jensen, E.V.2
Nilsson, S.3
Rylander, T.4
Warner, M.5
Gustafsson, J.A.6
-
25
-
-
33544471177
-
Applied logistic regression
-
John Wiley & Sons, editors. New York
-
Hosmer DW and Lemeshow SL. Applied logistic regression. In: John Wiley & Sons, editors. Wiley Interscience. New York; 1989.
-
(1989)
Wiley Interscience
-
-
Hosmer, D.W.1
Lemeshow, S.L.2
-
27
-
-
0035122520
-
Estrogen receptor β expression in invasive breast cancer
-
Mann S, Laucirica R, Carlson N, et al. Estrogen receptor β expression in invasive breast cancer. Hum Pathol 2001;32:113-8.
-
(2001)
Hum Pathol
, vol.32
, pp. 113-118
-
-
Mann, S.1
Laucirica, R.2
Carlson, N.3
-
28
-
-
0037011662
-
Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
-
Murphy LC, Leygue E, Niu Y, Snell L, Ho SM, Watson PH. Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. Br J cancer 2002;87:1411-6.
-
(2002)
Br J Cancer
, vol.87
, pp. 1411-1416
-
-
Murphy, L.C.1
Leygue, E.2
Niu, Y.3
Snell, L.4
Ho, S.M.5
Watson, P.H.6
-
29
-
-
0033231027
-
Increased expression of receptor β mRNA in tamoxifen-resistant breast cancer patients
-
Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL. Increased expression of receptor β mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 1999;59:5421-4.
-
(1999)
Cancer Res
, vol.59
, pp. 5421-5424
-
-
Speirs, V.1
Malone, C.2
Walton, D.S.3
Kerin, M.J.4
Atkin, S.L.5
-
30
-
-
4444293615
-
Effects on breast cancer: Clinical aspects
-
Lindsay R, Dempster DW, Jordan VC, editors. Philadelphia: Lippincott-Raven Publishers
-
Pritchard K. Effects on breast cancer: clinical aspects. In: Lindsay R, Dempster DW, Jordan VC, editors. Estrogens and antiestrogens. Philadelphia: Lippincott-Raven Publishers; 1997. p. 175-210.
-
(1997)
Estrogens and Antiestrogens
, pp. 175-210
-
-
Pritchard, K.1
-
31
-
-
0036735297
-
Expression of estrogen receptor (ER) βcx protein in ERα positive breast cancer. Specific correlation with progesterone receptor
-
Saji S, Omoto Y, Shimizu C, et al. Expression of estrogen receptor (ER) βcx protein in ERα positive breast cancer. Specific correlation with progesterone receptor. Cancer Res 2002;62:4849-53.
-
(2002)
Cancer Res
, vol.62
, pp. 4849-4853
-
-
Saji, S.1
Omoto, Y.2
Shimizu, C.3
-
32
-
-
0141995803
-
Reduced expression of estrogen receptor β in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model
-
Skrilis GP, Munot K, Bell SM, et al. Reduced expression of estrogen receptor β in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model. J Pathol 2003; 201:213-20.
-
(2003)
J Pathol
, vol.201
, pp. 213-220
-
-
Skrilis, G.P.1
Munot, K.2
Bell, S.M.3
-
33
-
-
0037506015
-
Estrogen receptor β protein in human breast cancer: Correlation with clinical tumor parameters
-
Fuqua SAW, Schiff R, Parra I, et al. Estrogen receptor β protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res 2003;63:2434-9.
-
(2003)
Cancer Res
, vol.63
, pp. 2434-2439
-
-
Fuqua, S.A.W.1
Schiff, R.2
Parra, I.3
-
34
-
-
0037420192
-
Role of the estrogen receptor coactivator AIB-1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
-
Osbome CK, Bardou V, Hopp TA, et al. Role of the estrogen receptor coactivator AIB-1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst (Bethesda) 2003;95:353-61.
-
(2003)
J Natl Cancer Inst (Bethesda)
, vol.95
, pp. 353-361
-
-
Osbome, C.K.1
Bardou, V.2
Hopp, T.A.3
-
35
-
-
0037192501
-
Molecular determinants for the tissue specificity of SERMs
-
Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science (Wash DC) 2002;295:2465-8.
-
(2002)
Science (Wash DC)
, vol.295
, pp. 2465-2468
-
-
Shang, Y.1
Brown, M.2
-
36
-
-
0034664769
-
Combinatorial roles of the nuclear receptor corepressor in transcription and development
-
Jepsen K, Hermanson O, Onami TM, et al. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 2000;102:753-63.
-
(2000)
Cell
, vol.102
, pp. 753-763
-
-
Jepsen, K.1
Hermanson, O.2
Onami, T.M.3
|